BioVie Inc. (BIVI) NASDAQ
$0.49 (0.01) (-1.42%)
Market Cap: $30.01M
As of 05/17/24 04:00 PM EDT. Market closed.
BioVie Inc. (BIVI)
NASDAQ
$0.49
(0.01) (-1.42%)
Market Cap: $30.01M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
biovie inc. (otc pink: bivi) is developing novel drug therapies for life-threatening complications of chronic liver disease. our initial target is ascites, which can occur in patients with advanced cirrhosis due to hepatitis, nash (non-alcoholic steatohepatitis), or alcoholism. ascites affects about 100,000 americans and carries an estimated 40% mortality rate within two years of being diagnosed. ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
8
Address
.
PRICE CHART FOR BIOVIE INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.49
Previous Close
$0.50
Days Range
$0.49 - $0.50
52 week range
$0.45 - $7.63
Volume
220,840
Avg. Volume (30 days)
436,831
Market Cap
$30.01M
Dividend Yield
-
P/E
-
Shares Outstanding
61,018,606
Open
$0.49
Previous Close
$0.50
Days Range
$0.49 - $0.50
52 week range
$0.45 - $7.63
Volume
220,840
Avg. Volume (30 days)
436,831
Market Cap
$30.01M
Dividend Yield
-
P/E
-
Shares Outstanding
61,018,606
FINANCIAL STATEMENTS FOR BIOVIE INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR BIOVIE INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| GORLIN STEVE | Director | Dec 01, 2023 | Sale | $1.69 | 75,680 | 127,899 | 46,358 | Dec 06, 2023, 04:16 PM |
| DO CUONG V | President & CEO | Nov 30, 2023 | Buy | $1.78 | 10,000 | 17,800 | 68,759 | Dec 01, 2023, 06:26 PM |
| GORLIN STEVE | Director | Sep 05, 2023 | Sale | $3.05 | 8,560 | 26,108 | 75,680 | Sep 07, 2023, 06:20 PM |
| BERMAN RICHARD J | Director | Aug 22, 2023 | Sale | $3.50 | 10,805 | 37,827 | 16,789 | Aug 24, 2023, 08:33 PM |
| BERMAN RICHARD J | Director | Jun 07, 2023 | Sale | $5.81 | 5,984 | 34,782 | 23,210 | Jun 15, 2023, 05:15 PM |
| BERMAN RICHARD J | Director | May 22, 2023 | Sale | $6.50 | 5,000 | 32,506 | 29,194 | Jun 15, 2023, 05:15 PM |
| BERMAN RICHARD J | Director | Mar 27, 2023 | Sale | $8.52 | 3,371 | 28,711 | 41,807 | Apr 06, 2023, 09:02 PM |
| BERMAN RICHARD J | Director | Mar 28, 2023 | Sale | $8.52 | 7,613 | 64,870 | 36,807 | Apr 06, 2023, 09:02 PM |
| Palumbo Joseph M | Chief Medical Officer | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 37,148 | Feb 22, 2023, 07:31 PM |
| DO CUONG V | CEO & President | Feb 16, 2023 | Option Exercise | $6.12 | 4,953 | 30,312 | 229,895 | Feb 22, 2023, 05:49 PM |
| KIM JOANNE WENDY | Chief Financial Officer | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 39,148 | Feb 22, 2023, 05:49 PM |
| Ahlem Clarence N. | EVP Neuroscience Product Dev. | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 37,148 | Feb 22, 2023, 05:48 PM |
| READING CHRISTOPHER | EVP Neuroscience R&D | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 37,148 | Feb 22, 2023, 05:47 PM |
| MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | Feb 16, 2023 | Option Exercise | $6.12 | 2,476 | 15,153 | 47,841 | Feb 22, 2023, 05:47 PM |
| PEIZER TERREN S | Director | Jun 24, 2019 | Option Exercise | $45.00 | 1,526,334 | 68,685,030 | 3,127,934 | Aug 26, 2022, 05:10 PM |
| PEIZER TERREN S | Director | Sep 22, 2020 | Option Exercise | $0.00 | 1,549,750 | 155 | 11,168,538 | Aug 26, 2022, 05:10 PM |
| PEIZER TERREN S | Director | Aug 15, 2022 | Option Exercise | $1.65 | 3,636,364 | 6,000,001 | 23,166,210 | Aug 16, 2022, 05:11 PM |
| KIM JOANNE WENDY | CFO | Dec 07, 2021 | Buy | $5.40 | 2,000 | 10,798 | 2,000 | Dec 09, 2021, 04:46 PM |
| GORLIN STEVE | Director | Nov 03, 2020 | Buy | $7.95 | 2,430 | 19,318 | 45,100 | Dec 15, 2020, 03:01 PM |
| GORLIN STEVE | Director | Oct 30, 2020 | Buy | $7.97 | 2,570 | 20,483 | 42,670 | Dec 15, 2020, 03:00 PM |
| GORLIN STEVE | Director | Oct 21, 2020 | Buy | $9.19 | 5,000 | 45,950 | 40,100 | Oct 22, 2020, 03:10 PM |
| GORLIN STEVE | Director | Oct 15, 2020 | Buy | $10.19 | 5,100 | 51,967 | 25,100 | Oct 19, 2020, 02:59 PM |
| GORLIN STEVE | Director | Oct 15, 2020 | Buy | $10.06 | 10,000 | 100,550 | 35,100 | Oct 19, 2020, 02:59 PM |
| GORLIN STEVE | Director | Oct 09, 2020 | Buy | $9.61 | 282 | 2,710 | 20,000 | Oct 14, 2020, 02:07 PM |
| GORLIN STEVE | Director | Oct 07, 2020 | Buy | $9.42 | 4,718 | 44,444 | 19,718 | Oct 14, 2020, 02:05 PM |
| GORLIN STEVE | Director | Sep 22, 2020 | Buy | $10.00 | 15,000 | 150,000 | 15,000 | Oct 14, 2020, 01:49 PM |
| Kumar Hari | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 727,272 | Mar 13, 2019, 05:39 PM |
| Kumar Hari | Director | Jun 15, 2018 | Option Exercise | $0.02 | 100,000 | 2,000 | 527,272 | Mar 13, 2019, 05:32 PM |
| Kumar Hari | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 427,272 | Mar 13, 2019, 05:32 PM |
| Kumar Hari | Director | Aug 14, 2017 | Option Exercise | $0.22 | 90,908 | 20,000 | 227,272 | Mar 13, 2019, 05:32 PM |
| Adams Jonathan M | Chief Operating Officer | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 6,303,521 | Feb 05, 2019, 04:05 PM |
| Sherman Michael Edward | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 718,181 | Feb 05, 2019, 03:58 PM |
| Do Cuong V | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 2,871,354 | Feb 05, 2019, 03:51 PM |
| Sooch Mina | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 813,636 | Feb 05, 2019, 03:37 PM |
| Lang James Paul | Director | Jan 02, 2019 | Option Exercise | $0.04 | 200,000 | 7,000 | 450,000 | Feb 05, 2019, 02:49 PM |
| Adams Jonathan M | Chief Operating Officer | Jul 03, 2018 | Option Exercise | $1.50 | 10,000 | 15,000 | 10,000 | Nov 01, 2018, 03:50 PM |
| Do Cuong V | Director | Jul 03, 2018 | Option Exercise | $1.50 | 86,666 | 129,999 | 86,666 | Nov 01, 2018, 03:40 PM |
| Lang James Paul | Director | Jul 03, 2018 | Option Exercise | $1.50 | 20,000 | 30,000 | 20,000 | Nov 01, 2018, 03:23 PM |
| Lang James Paul | Director | Jul 28, 2017 | Option Exercise | $0.22 | 113,636 | 25,000 | 363,636 | Aug 15, 2018, 03:48 PM |
| Lang James Paul | Director | Jan 02, 2018 | Option Exercise | $0.15 | 366,667 | 55,000 | 730,303 | Aug 15, 2018, 03:48 PM |
| Sooch Mina | Director | Apr 30, 2018 | Option Exercise | $0.02 | 150,000 | 3,600 | 613,636 | Aug 14, 2018, 06:14 PM |
| Sooch Mina | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 463,636 | Aug 14, 2018, 06:14 PM |
| Do Cuong V | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 2,871,354 | Aug 14, 2018, 03:39 PM |
| Do Cuong V | Director | Jan 08, 2018 | Option Exercise | $0.15 | 166,667 | 25,000 | 3,038,021 | Aug 14, 2018, 03:39 PM |
| Anderson Julie G | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 300,000 | Aug 09, 2018, 07:14 PM |
| Anderson Julie G | Director | May 31, 2018 | Option Exercise | $0.02 | 68,500 | 1,096 | 368,500 | Aug 09, 2018, 07:14 PM |
| Adams Jonathan M | chief operating officer | Jul 27, 2017 | Option Exercise | $0.22 | 45,454 | 10,000 | 5,903,521 | Aug 09, 2018, 06:36 PM |
| Sherman Michael Edward | Director | Jul 03, 2018 | Option Exercise | $1.50 | 16,666 | 24,999 | 16,666 | Aug 01, 2018, 04:26 PM |
| Sherman Michael Edward | Director | May 15, 2018 | Option Exercise | $0.02 | 250,000 | 4,500 | 518,181 | Aug 01, 2018, 04:26 PM |
| Sherman Michael Edward | Director | Jan 02, 2018 | Option Exercise | $0.15 | 200,000 | 30,000 | 268,181 | Aug 01, 2018, 04:26 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| GORLIN STEVE | Director | 12/01/2023 | 127,899 |
| DO CUONG V | President & CEO | 11/30/2023 | 17,800 |
| GORLIN STEVE | Director | 09/05/2023 | 26,108 |
| BERMAN RICHARD J | Director | 08/22/2023 | 37,827 |
| BERMAN RICHARD J | Director | 06/07/2023 | 34,782 |
| BERMAN RICHARD J | Director | 05/22/2023 | 32,506 |
| BERMAN RICHARD J | Director | 03/27/2023 | 28,711 |
| BERMAN RICHARD J | Director | 03/28/2023 | 64,870 |
| Palumbo Joseph M | Chief Medical Officer | 02/16/2023 | 15,153 |
| DO CUONG V | CEO & President | 02/16/2023 | 30,312 |
| KIM JOANNE WENDY | Chief Financial Officer | 02/16/2023 | 15,153 |
| Ahlem Clarence N. | EVP Neuroscience Product Dev. | 02/16/2023 | 15,153 |
| READING CHRISTOPHER | EVP Neuroscience R&D | 02/16/2023 | 15,153 |
| MARKHAM PENELOPE | EVP Liver Cirrhosis R&D | 02/16/2023 | 15,153 |
| PEIZER TERREN S | Director | 06/24/2019 | 68,685,030 |
| PEIZER TERREN S | Director | 09/22/2020 | 155 |
| PEIZER TERREN S | Director | 08/15/2022 | 6,000,001 |
| KIM JOANNE WENDY | CFO | 12/07/2021 | 10,798 |
| GORLIN STEVE | Director | 11/03/2020 | 19,318 |
| GORLIN STEVE | Director | 10/30/2020 | 20,483 |
| GORLIN STEVE | Director | 10/21/2020 | 45,950 |
| GORLIN STEVE | Director | 10/15/2020 | 51,967 |
| GORLIN STEVE | Director | 10/15/2020 | 100,550 |
| GORLIN STEVE | Director | 10/09/2020 | 2,710 |
| GORLIN STEVE | Director | 10/07/2020 | 44,444 |
| GORLIN STEVE | Director | 09/22/2020 | 150,000 |
| Kumar Hari | Director | 01/02/2019 | 7,000 |
| Kumar Hari | Director | 06/15/2018 | 2,000 |
| Kumar Hari | Director | 01/02/2018 | 30,000 |
| Kumar Hari | Director | 08/14/2017 | 20,000 |
| Adams Jonathan M | Chief Operating Officer | 01/02/2019 | 7,000 |
| Sherman Michael Edward | Director | 01/02/2019 | 7,000 |
| Do Cuong V | Director | 01/02/2019 | 7,000 |
| Sooch Mina | Director | 01/02/2019 | 7,000 |
| Lang James Paul | Director | 01/02/2019 | 7,000 |
| Adams Jonathan M | Chief Operating Officer | 07/03/2018 | 15,000 |
| Do Cuong V | Director | 07/03/2018 | 129,999 |
| Lang James Paul | Director | 07/03/2018 | 30,000 |
| Lang James Paul | Director | 07/28/2017 | 25,000 |
| Lang James Paul | Director | 01/02/2018 | 55,000 |
| Sooch Mina | Director | 04/30/2018 | 3,600 |
| Sooch Mina | Director | 01/02/2018 | 30,000 |
| Do Cuong V | Director | 01/02/2018 | 30,000 |
| Do Cuong V | Director | 01/08/2018 | 25,000 |
| Anderson Julie G | Director | 01/02/2018 | 30,000 |
| Anderson Julie G | Director | 05/31/2018 | 1,096 |
| Adams Jonathan M | chief operating officer | 07/27/2017 | 10,000 |
| Sherman Michael Edward | Director | 07/03/2018 | 24,999 |
| Sherman Michael Edward | Director | 05/15/2018 | 4,500 |
| Sherman Michael Edward | Director | 01/02/2018 | 30,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN BIOVIE INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 327,930 | 0% | -6.43% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 347,400 | 0.00029% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 247,106 | 0.00001% | 31.73% | Other |
CHANGE IN SHARES OUTSTANDING FOR BIOVIE INC
STOCK BUYBACKS FOR BIOVIE INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
17.37%
1Q
09/30/2023
21.93%
2Q
06/30/2023
23.48%
3Q
03/31/2023
26.82%
4Q
12/31/2022
43.74%
5Q
09/30/2022
64.63%
6Q
06/30/2022
79.32%
7Q
03/31/2022
79.32%
8Q
12/31/2021
79.47%
9Q
09/30/2021
88.88%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BIOVIE INC
LOADING...